Abstract
Since the first human heart transplantation in 1967 [1], cardiac transplantation has evolved from a medical curiosity to an accepted therapy for end-stage cardiomyopathy. Initial 1-year survival was only about 20%. With the general availability of cyclosporine in 1986, 1-year survival improved to more than 80%, with current 1-year survival now approaching 90% at high-volume transplant centers. Accordingly, the number of transplantations increased worldwide from 90 in 1981 to 2000 in 1988 to 3122 in 2001 [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnard CN: A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967, 41: 1271–1274.
Taylor D, Edwards L, Mohacsi P, et al.: The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report 2003. J Heart Lung Transplant 2003, 22: 616–24.
Gummert JF, Ikonen T, Morris RE: Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999, 10: 1366–1380.
Kobashigawa JA: Postoperative management following heart transplantation. Transplant Proc 1999, 31: 2038–2046.
Young JB, Winters WL, Bourge R, Uretsky BF: 24th Bethesda Conference: Cardiac Transplantation. Task Force 4: Function of the Heart Transplant Recipient. J Am Coll Cardiol 1993, 22: 31–41.
Evans RW, Manninen DL, Garrison LP Jr, Maier AM: Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986, 255: 1892–1898.
Goldstein D, Oz M, Rose E: Implantable left ventricular assist devices. N Engl J Med 1998, 339: 1522–1533.
Rose E, Gelijns A, Moskovitz A, et al.: Long term use of a left ventricular assist device for end stage heart failure. N Engl J Med 2001, 345: 1435–1443
Mancini DM, Eisen H, Kussmaul W, et al.: Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778–786.
Zugck C, Haunstetter A, Kruger C, et al.: Impact of beta blocker treatment on the prognostic value of currently used risk factors in congestive heart failure. J Am Coll Cardiol 2002, 39:1615–1622.
Costanzo MR: Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995, 92: 3593–3612.
Lurid L, Aaronson K, Mancini D: Predicting survival in ambulatory patients with severe heart failure on beta blocker therapy. Am J Cardiol, 2003, 92: 1350–1354.
Aaronson KD, Schwartz JS, Chen TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2597–2599.
Shumway NE, Lower RR, Stofer RC: Transplantation of the heart. Adv Surg 1966, 2: 265–284
Kawaguchi A, Gandjbakhch I, Pavie A, et al.: Factors affecting survival after heterotopic heart transplantation. J Thorac Cardiovasc Surg 1989, 98: 928–934.
Cooley DA: Techniques in Cardiac Surgery, edn 2. Philadelphia: WB Saunders; 1984: 372.
El Gamel A, Yonan NA, Grant S, et al.: Orthotopic cardiac transplantation: a comparison of standard and bicaval Wythenshawe techniques. J Thorac Cardiovasc Surg 1995, 109:721–730.
Cerilli GJ: Organ Transplantation and Replacement. Philadelphia: JB Lippincott; 1988.
Unverferth DV: Dilated Cardiomyopathy. Mt. Kisco, NY: Futura Publishing Co; 1985.
Fishman J, Rubin R: Infection in organ transplant recipients. N Engl J Med 1998, 338: 1741–1751.
Paris W, Woodbury A, Thompson S, et al.: Returning to work after heart transplantation. J Heart Lung Transplant 1993, 12: 46–54.
Beniaminovitz A, Coromilas J, Oz M, et al.: Electrical connection of native and transplanted sinus nodes via atrial pacing improves exercise performance after cardiac transplantation. Am J Cardiol 1998, 81:1373–1377.
Michler RE, McLaughlin MJ, Chen JM, et al.: Clinical experience with cardiac retransplantation. J Thorac Cardiovasc Surg 1993, 106:622–629.
Ventura HO, Mehra MR, Smart FW, Stapleton DD: Cardiac allograft vasculopathy: current concepts. Am Heart J 1995, 129: 791–798.
Costanzo-Nordin MR: Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant 1992, 11 (suppl): 90–104.
Johnson MR: Transplant coronary artery disease: nonimmunologic risk factors. J Heart Lung Transplant 1992, 11 (suppl): 124–132.
McDonald K, Rector TS, Braunlin EA, et al.: Association of coronary artery disease in transplant recipients with cytomegalovirus infection. Am J Cardiol 1989, 64:359–362.
Mancini D, Pinney S, Burkhoff D, et al.: Use of rapamycin slows progression of cardiac transplant vasculopathy. Circulation 2003, 108:48–53.
Eisen H, Dorent R, Kobashigawa J, et al.: Efficacy and safety of everolimus as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: 12 month results. N Engl J Med 2003, 349: 847–58.
Helman D, Morales D, Edwards N, et al.: Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 1999, 68:1187–1194.
Higgins RSD, Silverman NA: Status of permanent cardiac replacement for end-stage congestive heart failure. Heart Failure Reviews 1996, 1: 39–52.
Kaplon R, Oz M, Kwiatowski K, et al: Miniature axial flow pump for ventricular assistance in children and small adults. J Thorac Cardiovasc Surg 1996, 111: 13–18.
Sabbah H, Chaudhry P, Paone G, et al.: Passive ventricular constraint with the ACORN prosthetic jacket prevents progressive left ventricular dilation and improves ejection fraction in dogs with moderate heart failure. J Am Coll Cardiol 1999, 33: 207A.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mancini, D.M. (2005). Cardiac Transplantation. In: Colucci, W.S. (eds) Atlas of HEART FAILURE. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4558-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4558-0_14
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4560-3
Online ISBN: 978-1-4757-4558-0
eBook Packages: Springer Book Archive